変異株に対する免疫応答


Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
 Planas D, Veyer D, Baidaliuk A, et al. 〔Nature. 2021 Aug;596(7871):276-280〕(査読済み)


mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
 Chemaitelly H, Yassine HM, Benslimane FM, et al. 〔Nat Med. 2021 Jul 9〕(査読済み)


Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
 Charmet T, Schaeffer L, Grant R, et al. 〔Lancet Reg Health Eur. 2021 Sep;8:100171〕(査読済み)


Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
 Barros-Martins J, Hammerschmidt SI, Cossmann A, et al. 〔Nat Med. 2021 Jul 14〕(査読済み)


Efficacy of COVID-19 vaccines: Several modes of expression should be presented in scientific publications
 Montastruc JL, Biron P, Sommet A, et al. 〔Fundam Clin Pharmacol. 2021 Jul 1〕(査読済み)